Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Lupus Nephritis
100%
Urinary Biomarkers
100%
Disease Activity
100%
Markov
100%
Biomarker Panel
100%
Multistate Model
100%
Predicting Change
100%
α1-acid Glycoprotein
83%
Ceruloplasmin
83%
AICc
66%
Hazard Ratio
33%
Remission
33%
State Transition
33%
Transition Hazard
33%
95% Confidence Interval
33%
Transferrin
16%
Prospective Clinical Trial
16%
Clinical Data
16%
Lupus
16%
South African
16%
Monocyte Chemoattractant protein-1 (MCP-1)
16%
Clinical Biomarkers
16%
Demographic Data
16%
Vascular Cell Adhesion molecule-1 (VCAM-1)
16%
Albert Einstein
16%
Urine Samples
16%
Routine Care
16%
Predictive Factors
16%
Pediatric Lupus
16%
United Kingdom
16%
Lipocalin
16%
Prostaglandin D Synthase
16%
Corrected Akaike Information Criterion
16%
Longitudinal Observation
16%
State-space Model
16%
State Probability
16%
Multi-state Markov Model
16%
Lead Monitoring
16%
Markov State Space
16%
Enzyme-like
16%
Juvenile Systemic Lupus Erythematosus (jSLE)
16%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Lupus Erythematosus Nephritis
100%
Disease Activity
100%
Orosomucoid
83%
Ceruloplasmin
83%
Remission
33%
Cohort Study
16%
Clinical Trial
16%
Systemic Lupus Erythematosus
16%
Vascular Cell Adhesion Molecule 1
16%
Enzymes
16%
Transferrin
16%
Monocyte Chemotactic Protein 1
16%
Akaike Information Criterion
16%
Lipocalin
16%
Prostaglandin D Synthase
16%
Immunology and Microbiology
Lupus Erythematosus
100%
Nephritis
100%
Orosomucoid
62%
Ceruloplasmin
62%
Systemic Lupus Erythematosus
12%
VCAM-1
12%
Monocyte Chemotactic Protein 1
12%
Urine Sampling
12%
Prostaglandin D
12%
Lipocalin
12%